Related Experiment Video
Updated: Jun 23, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in HIV-infected
T Tony Trinh1, William R Short, Leonard A Mermel
1Department of Medicine, The Warren Alpert Medical School of Brown University and Rhode Island Hospital, Providence, Rhode Island, USA. ttonytrinh@gmail.com
Background:
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) has emerged as the most common cause of skin and soft tissue infections (SSTIs).
Methods:
Retrospective chart review of 43 adult HIV-infected patients with CA-MRSA SSTI was conducted.
Results:
Antibiotic susceptibility was as follows: vancomycin (100%), rifampin (100%), gentamicin (97.7%), tetracycline (96.5%), trimethoprim-sulfamethoxazole (95.2%), clindamycin (89.5%), levofloxacin (66.7%), and erythromycin (6.9%). At SSTI presentation, 58.5% of patients had CD4 counts greater than 200 cells/uL, 82.9% had a viral load (VL) below 100 000 log copies/mL, 6 of whom had undetectable VL. All 43 patients received empiric antibiotic therapy. Additionally, 34 patients underwent incision and drainage (I&D). For the 37 patients with follow-up data available at 4 weeks, 30 of the infections were resolved/resolving and 7 had no improvement or worsened.
Conclusion:
A majority of our patients with CA-MRSA SSTI did not have immunological/virological markers consistent with severe HIV/AIDS disease at time of presentation.
Insights
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin infections in HIV patients often present without severe immune deficiency. Most patients responded well to antibiotic treatment and surgical intervention.
Area of Science:
- Infectious Diseases
- HIV/AIDS Research
- Dermatology
Background:
- Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) is a leading cause of skin and soft tissue infections (SSTIs).
- Understanding CA-MRSA in immunocompromised populations like HIV-infected individuals is crucial.
Purpose of the Study:
- To analyze the clinical characteristics and treatment outcomes of CA-MRSA SSTIs in adult HIV-infected patients.
- To assess the immunological and virological status of these patients at the time of infection.
Main Methods:
- Retrospective chart review of 43 adult HIV-infected patients diagnosed with CA-MRSA SSTI.
- Analysis of antibiotic susceptibility, CD4 counts, viral load, treatment regimens, and patient outcomes.
Main Results:
- High susceptibility rates were observed for vancomycin (100%) and rifampin (100%).
- Most patients presented with CD4 counts >200 cells/uL and viral loads <100,000 copies/mL.
- Treatment including antibiotics and incision/drainage (I&D) led to resolution or improvement in 30 out of 37 patients with follow-up.
Conclusions:
- CA-MRSA SSTIs in this cohort of HIV-infected patients typically did not coincide with severe immunodeficiency or uncontrolled viral replication.
- These findings suggest that standard treatment approaches for CA-MRSA SSTIs are generally effective in HIV-infected individuals without advanced disease.
Related Concept Videos
Staphylococcal Skin Infections
Cryptococcal Meningitis
Clinical Significance of Antibiotic Resistance
Sexually Transmitted Infections
Mechanism of Antibiotic Resistance in MRSA
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...